CRISAFULLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.987
AS - Asia 1.060
EU - Europa 801
SA - Sud America 159
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 22
AN - Antartide 1
OC - Oceania 1
Totale 4.082
Nazione #
US - Stati Uniti d'America 1.911
SG - Singapore 415
IT - Italia 353
CN - Cina 230
HK - Hong Kong 129
BR - Brasile 127
DE - Germania 94
BD - Bangladesh 76
VN - Vietnam 74
FI - Finlandia 59
GB - Regno Unito 53
FR - Francia 48
TR - Turchia 36
CA - Canada 34
RU - Federazione Russa 31
UA - Ucraina 29
IE - Irlanda 24
IN - India 18
NL - Olanda 18
PL - Polonia 18
MX - Messico 16
AT - Austria 12
IQ - Iraq 12
ID - Indonesia 11
SE - Svezia 11
ZA - Sudafrica 11
JP - Giappone 10
AR - Argentina 9
ES - Italia 9
SA - Arabia Saudita 9
JM - Giamaica 8
MK - Macedonia 7
VE - Venezuela 7
CO - Colombia 6
CZ - Repubblica Ceca 6
PH - Filippine 6
CR - Costa Rica 5
EC - Ecuador 5
EG - Egitto 5
GR - Grecia 5
AL - Albania 4
LB - Libano 4
UZ - Uzbekistan 4
EE - Estonia 3
GP - Guadalupe 3
HN - Honduras 3
LT - Lituania 3
PK - Pakistan 3
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
CH - Svizzera 2
DK - Danimarca 2
DZ - Algeria 2
IL - Israele 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PR - Porto Rico 2
PT - Portogallo 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
Totale 4.031
Città #
Singapore 251
Ashburn 231
San Jose 220
Hong Kong 128
Council Bluffs 102
Dallas 84
Fairfield 82
New York 76
The Dalles 58
Beijing 55
Los Angeles 46
Munich 45
Houston 42
Chandler 41
Helsinki 37
Columbus 35
Milan 34
Princeton 34
Santa Clara 32
Seattle 32
North Bergen 31
Rome 31
Wilmington 29
Brescia 27
Istanbul 27
Lauterbourg 27
Woodbridge 27
Ho Chi Minh City 25
Cambridge 24
Dublin 24
Jacksonville 24
Buffalo 19
Chicago 19
Turku 19
Palermo 18
Shanghai 18
San Francisco 17
Atlanta 16
Phoenix 16
Ann Arbor 14
Warsaw 14
Denver 13
Hanoi 13
Redondo Beach 13
Toronto 12
Turin 12
São Paulo 11
Frankfurt am Main 9
Orem 9
Moscow 8
Nuremberg 8
San Diego 8
Tokyo 8
Bologna 7
Johannesburg 7
London 7
Tianjin 7
Vienna 7
Amsterdam 6
Boardman 6
Des Moines 6
Kingston 6
Poplar 6
Bergamo 5
Catania 5
Changsha 5
Chennai 5
Crotone 5
Haiphong 5
San José 5
Washington 5
Alexandria 4
Bosio 4
Brasília 4
Dosso 4
Erbil 4
Florence 4
Fortaleza 4
Jinan 4
Kolkata 4
Manchester 4
Mexico City 4
Montreal 4
Naples 4
Ottawa 4
Padova 4
Paris 4
Rio de Janeiro 4
Romola 4
Tashkent 4
Belo Horizonte 3
Biên Hòa 3
Boston 3
Brno 3
Brooklyn 3
Cape Town 3
Castelli Calepio 3
Desenzano del Garda 3
Duncan 3
Elk Grove Village 3
Totale 2.466
Nome #
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 227
SALUTE RIPRODUTTIVA NELLE PAZIENTI CON MALATTIE REUMATOLOGICHE SEGUITE PROSPETTICAMENTE DA TEAM MULTIDISCIPLINARI: ANALISI DELL’OUTCOME MATERNO-FETALE, VALUTAZIONE DELLA TERAPIA IN GRAVIDANZA E IDENTIFICAZIONE DI FATTORI DI RISCHIO PER EVENTI AVVERSI 216
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 194
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 182
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study 165
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 134
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 131
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 131
Does seronegative obstetric APS exist? “pro” and “cons” 128
Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. 123
Impact of COVID-19 on outpatient therapy with iloprost for systemic sclerosis digital ulcers 122
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 120
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 119
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 116
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study 115
Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes 111
Pregnancy and reproductive aspects of systemic lupus erythematosus 110
Managing puerperium in patients with systemic autoimmune diseases: an update 108
Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes 106
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 99
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 95
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 92
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 89
Retention rate of IL-1 inhibitors in Schnitzler's syndrome 83
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 81
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 80
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 80
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network 76
Women of childbearing age living with spondyloarthritis: time for improving knowledge and counselling about reproductive issues 75
Reproductive Health in Scleroderma, Vasculitis, and Sjögren Syndrome 74
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study) 74
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 69
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 53
The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review 50
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel 46
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus 36
Risk of major organ involvement in Behçet’s patients with mucocutaneous onset: data from the AIDA Network Registry 26
The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseases 24
Development and validation of a Relapsing Polychondritis disease-specific Quality of Life instrument (ERN ReCONNET RP-QoL) 22
Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrument 20
The Risk of Developing Ocular Involvement Among Behçet’s Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet’s Disease Registry 20
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries 18
Monoclonal Antibodies in Pregnancy of Patients with Systemic Lupus Erythematosus: Friend or Foe? A Case Report of a Patient with Multiple Pregnancies 16
European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT) 14
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network. 12
Totale 4.082
Categoria #
all - tutte 21.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022111 0 0 0 0 5 13 6 8 10 20 16 33
2022/2023138 22 7 2 2 14 39 5 10 23 1 7 6
2023/2024269 19 2 23 15 7 45 13 17 52 22 12 42
2024/2025720 15 13 23 78 81 69 53 43 66 50 143 86
2025/20261.749 132 161 151 193 170 125 256 84 112 180 123 62
2026/2027704 117 91 159 330 7 0 0 0 0 0 0 0
Totale 4.082